Council of Councils
Think Global Health
Online Store
COVID-19
For two years, the world has been battling COVID-19 with masks, vaccines, and lockdowns. But countries have largely failed to channel their shared experiences into a blueprint for action.
Feb 4, 2022
For two years, the world has been battling COVID-19 with masks, vaccines, and lockdowns. But countries have largely failed to channel their shared experiences into a blueprint for action.
Feb 4, 2022
-
In-Person DC Roundtable: National Security and the U.S. Pharma and Biotech IndustriesThe COVID-19 pandemic and chronic U.S. drug shortages highlight the health security and strategic importance of U.S. pharmaceutical and biotechnology capabilities during and between pathogenic crises. Geopolitical competition and interest in industrial policy for biotechnology further underscore the national security role of domestic biopharmaceutical infrastructure. Policymakers confront competing health, economic, and strategic priorities in maximizing innovation in technology, business models, and health-care systems in facilitating safe, accessible, secure, and sustainable products, services, and supply chains. Please join our speakers, Monique K. Mansoura, executive director for global health security and biotechnology at The MITRE Corporation, and Victor Suarez, Colonel (ret.), U.S. Army, senior fellow (visiting) at The Council on Strategic Risks and founder of BluZoneBio, to explore challenges facing the U.S. pharma and biotech industries and approaches to strengthening the national security resilience of those industries in a world marked by health and geopolitical threats.
-
Hybrid DC Roundtable: The CDC Response to the Spread of H5N1 Avian Flu in Dairy CowsAn outbreak of H5N1 avian influenza that was detected for the first time in a milking herd of cattle in Texas one month ago has now infected thirty-three herds in eight states and at least one farm worker, spurring alarm among some experts that human-to-human transmission could be next. Please join us for a discussion with Dr. Nirav D. Shah, Principal Deputy Director of the U.S Centers for Disease Control and Prevention, on the U.S. response to this avian flu outbreak and on how the CDC and its U.S. government counterparts are applying lessons from COVID-19 to respond to the potential threat.
-
China: Year in Review 2023A review of the most significant events in China in 2023, and a look ahead to the most pressing challenges and uncertainties the country will face in 2024.
-
The U.S. National Debt DilemmaAfter years of steadily increasing debt, federal spending has skyrocketed, taking U.S. debt to levels not seen since World War II.
-
Review of Beijing Rules: How China Weaponized Its Economy to Confront the WorldAccording to a new book by Axios reporter Bethany Allen, China has developed an authoritarian economic statecraft to reshape the global order.
-
What Is the U.S. Federal Reserve?Over the past decade, the Fed kept interest rates low while it deployed trillions of dollars in stimulus and expanded its regulatory oversight. Now, the central bank is back in the spotlight for its battle against inflation.
-
Negotiating Global Health Security
![]()
Lessons from the COVID-19 pandemic could revolutionize global health security, but the window for change is closing—quickly. In the latest Council Special Report, Yanzhong Huang and Rebecca Katz outline the urgent reforms that could lead to a safer, healthier world. -
ASEAN Summit, AMLO’s Final Year, COVID-19 Variants Emerge, and MoreSoutheast Asian leaders meet in Jakarta, Indonesia for the forty-third Association of Southeast Asian Nations (ASEAN) summit, working to improve the bloc’s cooperation with external partners; Mexican President Andrés Manuel López Obrador, commonly known as AMLO, begins the last year of his six-year term; new COVID-19 variants drive a spike in U.S. cases and hospitalizations; and U.S. Secretary of Commerce Gina Raimondo’s visit to Beijing spurs renewed interest in U.S.-China trade.
-
Anti-Corruption Campaign in China’s Medical Sector: Unmasking the Hidden AgendaWhile the Chinese government’s new anti-corruption campaign has the potential to significantly advance China’s healthcare reform, it may also have unforeseen and potentially dire consequences.
-
You Are Planning to Visit China: Here’s What You Need to KnowForeign visitors to China focusing solely on the political risks of entering China may overlook other important factors that are more immediately relevant when travelling in the country.
-
Judging How U.S. States Performed in the COVID-19 Pandemic Depends on the MetricThe United States struggled with COVID-19, but some states managed to keep deaths and infections relatively low without shutting society down or ignoring the crisis.
-
A New U.S. Foreign Policy for Global Health
![]()
The United States should treat pandemics and global warming as apex health threats to its national interests, argues David P. Fidler. -
Not All U.S. States Struggled Equally Against COVID-19The COVID-19 pandemic devastated the United States with over one million deaths over three years. Yet, the burden of the virus was not spread evenly across the country. States like Vermont and Washington had death rates comparable to well-performing countries in Scandinavia, while Mississippi and Arizona fared as poorly as the worst performing nations in the world, Russia and Peru. Speakers, Emma S. Castro and Joseph L. Dieleman from the Institute for Health Metrics and Evaluation, discuss the factors that contributed to those incredibly large cross-state differences in COVID-19 outcomes and the lessons learned from the parts of the United States that performed well.
-
The Quad’s Longevity Might Hinge on Its Health PlanEven though China might have spurred the Quad’s initial health response, the answer to its longevity lies in building sustainable future coordination.
-
China’s Post-COVID Recovery and ReopeningChina’s post-COVID recovery and reopening efforts are hindered by geopolitical rivalries and national security concerns.
